CI · News · 20260804N

Business Portfolio Review

Cigna Group · 2026-08-04 · Importance 31 · Surprise 42

Third-party reporting says Cigna is conducting an ongoing review of its business portfolio. The review is discussed alongside uncertainty over the company’s pharmacy benefit management operations and regulatory pressure in the United States. The reports provide no transaction announcement, timeline, or quantified financial effect from potential portfolio changes.

Key facts

• Significant insider selling of $59.4 million occurred over the past three months. source
• Cigna Group's stock (CI) fell 2.84% on Tuesday, closing at $274.05. source
• The company's stock is currently 13.13% below its 52-week high of $315.47, which was reached on October 3rd. source
• Jefferies has downgraded Cigna Group (CI) to a "Hold" rating, lowering its price target to $307 from $336. source